Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HE Capital Markets is a London-based investor relations, public relations, and capital markets advisory firm rather than a biotechnology, pharmaceutical, or healthcare operating company. The firm helps publicly traded and growth companies raise visibility with investors through shareholder communications, digital marketing, media outreach, and capital markets support. Its website highlights work across multiple sectors including pharmaceuticals, cannabis, psychedelics, mining, oil and gas, blockchain, and technology. For healthcare-related clients, HE Capital Markets appears to function as a communications and investor-access service provider, not as a developer of therapeutics, diagnostics, or medical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HE Capital Markets.